KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Gross Profit (2016 - 2025)

Historic Gross Profit for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $1.5 million.

  • Nektar Therapeutics' Gross Profit fell 8861.26% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year decrease of 6720.26%. This contributed to the annual value of $56.4 million for FY2024, which is 622.9% up from last year.
  • Per Nektar Therapeutics' latest filing, its Gross Profit stood at $1.5 million for Q3 2025, which was down 8861.26% from $851000.0 recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Gross Profit peaked at $20.7 million during Q2 2021, and registered a low of -$6.8 million during Q1 2025.
  • Over the past 5 years, Nektar Therapeutics' median Gross Profit value was $14.5 million (recorded in 2023), while the average stood at $13.3 million.
  • Per our database at Business Quant, Nektar Therapeutics' Gross Profit soared by 5440.62% in 2024 and then plummeted by 16517.16% in 2025.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Gross Profit stood at $18.8 million in 2021, then decreased by 16.22% to $15.8 million in 2022, then fell by 15.63% to $13.3 million in 2023, then surged by 54.41% to $20.6 million in 2024, then crashed by 92.74% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $851000.0 for Q2 2025, and -$6.8 million during Q1 2025.